piperacillin has been researched along with brl 28500 in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (31.58) | 18.7374 |
| 1990's | 5 (26.32) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darrell, JH; Miall-Allen, VM; Whitelaw, AG | 1 |
| Hiraga, Y; Ikuno, Y; Inoue, E; Miki, F; Murata, A; Saito, A; Sakamoto, K; Tahara, A; Tamizawa, M; Tanizawa, S | 1 |
| Bremner, DA | 1 |
| Bartzokas, CA; Mackie, MJ; Purohit, S; Reilly, JT | 1 |
| Cox, CE | 1 |
| Douglas, GF; File, TM; Johnson, LA; Salstrom, SJ; Tan, JS | 1 |
| Appelbaum, PC; Jacobs, MR; Pankuch, GA | 1 |
| Baughman, R; Boylen, CT; Chan, JC; Charan, NB; Cormier, YC; Erickson, A; Grossman, R; Kirmani, N; Shlaes, DM; Suh, B | 1 |
| Duncanson, FP; Norden, CW; Talan, DA; Tan, JS; Wishnow, RM | 1 |
| Erwin, ME; Jones, RN; Worth, S | 1 |
| Rokosz, A; Sawicka-Grzelak, A | 1 |
| Marcille, R; Sakarcan, A; Stallworth, J | 1 |
| Powell, LL; Wilson, SE | 1 |
| Bangsberg, DR; Chambers, HF; Charlebois, ED; Pang, S; Perdreau-Remington, F; Winston, LG | 1 |
| Olweny, J; Stucki, ZN; Torbert, DP; WaKabongo, M | 1 |
| Das, BK; Dhawan, B; Kapil, A; Mohanty, S; Singhal, R; Sood, S | 1 |
| Gurkan, E; Hutton-Thomas, R; Lakticová, V; Meyer, M; Rice, LB | 1 |
| Ampofo, K; Sherwin, CM; Spigarelli, MG; Stockmann, C; Waters, CD; Young, DC; Zobell, JT | 1 |
| Bergeron, L; Grégoire, JP; Lemieux, P; Thibeault, R | 1 |
2 review(s) available for piperacillin and brl 28500
| Article | Year |
|---|---|
The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection.
Topics: Abdomen; Abdominal Abscess; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Clavulanic Acids; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Surgical Wound Infection; Ticarcillin | 2000 |
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefepime; Ceftazidime; Cephalosporins; Clavulanic Acids; Cystic Fibrosis; Disease Progression; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin | 2013 |
7 trial(s) available for piperacillin and brl 28500
| Article | Year |
|---|---|
Ticarcillin plus clavulanic acid (Timentin) compared with standard antibiotic regimes in the treatment of early and late neonatal infections.
Topics: Bacterial Infections; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Female; Floxacillin; Gentamicins; Humans; Infant, Newborn; Male; Penicillins; Piperacillin; Ticarcillin | 1988 |
[Comparative study of BRL28500 (clavulanic acid-ticarcillin) and piperacillin in the treatment of respiratory tract infections].
Topics: Adult; Aged; Aged, 80 and over; beta-Lactamase Inhibitors; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Middle Aged; Penicillins; Piperacillin; Respiratory Tract Infections; Ticarcillin | 1987 |
A randomized trial of Timentin and tobramycin versus piperacillin and tobramycin in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillin Resistance; Penicillins; Piperacillin; Random Allocation; Sepsis; Ticarcillin; Tobramycin | 1986 |
Timentin versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
Topics: Adult; Aged; Bacteria; Bacterial Infections; Clavulanic Acids; Cross Infection; Drug Combinations; Drug Evaluation; Female; Humans; Male; Middle Aged; Penicillin Resistance; Penicillins; Piperacillin; Sepsis; Ticarcillin; Urinary Tract Infections | 1986 |
Timentin versus piperacillin or moxalactam in the therapy of acute bacterial infections.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Bacterial Infections; Clavulanic Acids; Drug Combinations; Female; Hallucinations; Humans; Male; Middle Aged; Moxalactam; Penicillins; Piperacillin; Sepsis; Ticarcillin | 1984 |
Piperacillin/tazobactam compared with ticarcillin/clavulanate in community-acquired bacterial lower respiratory tract infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Tazobactam; Ticarcillin | 1994 |
Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. The Piperacillin/Tazobactam Skin and Skin Structure Study Group.
Topics: Bacteroides Infections; Clavulanic Acids; Double-Blind Method; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus; Tazobactam; Ticarcillin | 1993 |
10 other study(ies) available for piperacillin and brl 28500
| Article | Year |
|---|---|
In vitro susceptibility of piperacillin v timentin and ticarcillin.
Topics: Clavulanic Acids; Drug Combinations; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas aeruginosa; Ticarcillin | 1987 |
Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Clavulanic Acids; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Piperacillin; Streptococcus pneumoniae; Sulbactam; Tazobactam; Ticarcillin | 1994 |
Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Clinical
Topics: Acetamides; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Azithromycin; Clavulanic Acids; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Naphthyridines; Oxazoles; Oxazolidinones; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quality Control; Roxithromycin; Ticarcillin | 1996 |
[Susceptibility of clinical strains of gram-positive bacteria to selected beta-lactam antibiotics].
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clavulanic Acids; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Species Specificity; Thienamycins; Ticarcillin | 1998 |
Antibiotic-induced recurring interstitial nephritis.
Topics: Adolescent; Biopsy; Clavulanic Acids; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Kidney; Methylprednisolone; Nephritis, Interstitial; Penicillins; Piperacillin; Ticarcillin | 2002 |
Impact of a formulary switch from ticarcillin-clavulanate to piperacillin-tazobactam on colonization with vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Carrier State; Clavulanic Acids; Cross Infection; Enterococcus faecium; Female; Formularies, Hospital as Topic; Gastrointestinal Tract; Humans; Intensive Care Units; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Risk Factors; Ticarcillin; Time Factors; Vancomycin Resistance | 2004 |
Effect of bovine lactoferrin on the MICs of ampicillin/sulbactam (UNASYN), amoxicillin/clavulanic acid (Augmentin), ticarcillin clavulanate (Timentin), and piperacillin-tazobactam (ZOSYN), against clinical and environmental isolates of motile Aeromonas.
Topics: Aeromonas; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Animals; Anti-Bacterial Agents; Cattle; Clavulanic Acids; Lactoferrin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Ticarcillin | 2005 |
Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acids; Cross Infection; Gram-Negative Bacteria; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Ticarcillin | 2005 |
Antibiotic-induced enterococcal expansion in the mouse intestine occurs throughout the small bowel and correlates poorly with suppression of competing flora.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Clavulanic Acids; Clindamycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Escherichia coli; Green Fluorescent Proteins; Intestine, Small; Metronidazole; Mice; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Ticarcillin | 2006 |
Higher risk of neutropenia associated with piperacillin-tazobactam compared with ticarcillin-clavulanate in children.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clavulanic Acids; Cohort Studies; Female; Humans; Infant; Male; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Assessment; Ticarcillin | 2015 |